News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
CDC Director Delivers Passionate Speech to Agency
Jim Daley | Mar 30, 2018
Robert Redfield emphasized the importance of science and data in meeting with employees.
Proposed US Spending Bill Boosts Science Funding
Shawna Williams | Mar 22, 2018
NIH, NSF, and the DOE’s Office of Science will be among the agencies with budget increases if the omnibus bill is passed.
AIDS Researcher Emerges as Top Candidate to Head CDC
Ashley Yeager | Mar 19, 2018
Robert Redfield would replace Brenda Fitzgerald, who resigned in January over unresolved conflicts of interest.
CDC, FDA Warn Against Kratom Use
Jim Daley | Feb 26, 2018
The herbal supplement, deemed an opioid by the FDA, was recently linked to a
outbreak in 20 states.
CDC: Flu Vaccine 36 Percent Effective So Far
Catherine Offord | Feb 16, 2018
The vaccine shows better-than-expected effectiveness against the most common and most virulent strain of influenza in children under 9 years old.
Proposed Federal Budget Slashes Funds to EPA, CDC
Diana Kwon | Feb 13, 2018
Funds for the NIH and NSF would stay flat, while some agencies, including the FDA and NASA, would see increases.
on PBS News Hour
Staff | Feb 11, 2018
Ashley Yeager, TS associate editor, explains the possible ramifications of cutting the CDC's Prevention and Public Health Fund.
Cuts to Prevention and Public Health Fund Puts CDC Programs at Risk
Ashley Yeager | Feb 9, 2018
Reductions from the budget passed today and a $750-million shift of funds to the Children’s Health Insurance Program add pressure to public health initiatives, including immunizations and outbreak responses.
CDC Identifies Seoul Virus Outbreak Among Pet Rat Owners
Diana Kwon | Feb 6, 2018
These are the first known cases of individuals catching the virus from their pets in Canada or the U.S.
CDC Director Resigns Over Unresolved Conflicts of Interest
Shawna Williams | Jan 31, 2018
Brenda Fitzgerald had drawn criticism for tobacco-related investments, among others.